Presentation of Celiac Disease




The mode of presentation of patients with celiac disease has changed dramatically over the recent decades, with diarrheal or classic presentations becoming less common. This trend is most markedly seen in children, whose main presentations include recurrent abdominal pain, growth issues, and screening groups at risk. Among adults, presentations include diarrhea, anemia, osteoporosis, and recognition at endoscopy performed for gastroesophageal reflux disease, as well as screening. The groups most commonly screened include family members of patients with celiac disease, Down syndrome, and autoimmune diseases.








  • Among children, celiac disease has a varied presentation, and is affected especially by the age at presentation.



  • In addition to the diverse spectrum of disease presentations and age-related variability of the manifestations of celiac disease in children, the shifting presentation of the disease over time is recognized.



  • While the list of conditions associated with celiac disease is quite extensive, there are several groups that are more frequently targeted for celiac disease screening because of their strong association.



Key Points


Children


Celiac disease was originally considered a pediatric disorder characterized by malabsorption and steatorrhea. Subsequently it was recognized that celiac disease could affect adults at any age, and, contrary to opinion at that time, children did not grow out of the disease. Most adults with celiac disease diagnosed before 1980 presented with diarrhea. With the advent of serologic tests in the 1980s, the wide spectrum of clinical manifestations became apparent.


Among children celiac disease has a varied presentation, and is affected especially by the age at presentation. Very young children present more often with “classic” celiac disease, characterized by diarrhea, abdominal distension, and failure to thrive. These younger patients are more likely to present with diarrheal or malabsorptive manifestations of the disease, whereas older children and adolescents are more likely to present with atypical gastrointestinal complaints such as pain, vomiting, or constipation. In addition, extraintestinal symptoms such as arthritis, neurologic symptoms, and anemia are not infrequent, as are asymptomatic cases. The authors’ experience shows that currently the vast majority of children with celiac disease present in 1 of the 3 following ways : (1) growth issues that include failure to thrive in the youngest children or short stature among older children ; (2) recurrent abdominal pain the cause of which is unclear, possibly related to episodic or transient intussusceptions that are being increasingly recognized to occur in both adults and children with celiac disease ; (3) at-risk children screened for the disease because either they were relatives of patients with celiac disease or they had one or more autoimmune disorders or Down syndrome. Based on our observation, only 9% of children present with diarrhea. In fact, diarrhea and the malabsorption syndrome are mainly evident in the very young (<2 years old). The authors’ experience differs from a series of pediatric patients from Spain in which 62% of the children presented with diarrhea.


In addition to the diverse spectrum of disease presentations and age-related variability of the manifestations of celiac disease in children, the shifting presentation of the disease over time is recognized. An overall decrease in the prevalence of diarrheal presentations over the past 2 decades, accompanied by an increase in atypical manifestations of the disease, has been well described in both adults and children. As an example of how much the presentation of celiac disease has changed, a recent study from the Netherlands revealed that celiac disease was more frequently represented in a cohort of children with chronic constipation fulfilling Rome III criteria for irritable bowel syndrome (IBS); celiac disease was more common than hypothyroidism and hypercalcemia as a cause of the constipation.


Overweight and obese children and adolescents with celiac disease are now frequently identified. The majority of North American children in the authors’ series had a normal body mass index; however, there were children who were overweight, only a minority of children studied were underweight. Similarly, adults may be obese at presentation of celiac disease.


More widespread use of serologic markers has facilitated the diagnosis of celiac disease in children. This fact alone does not entirely explain the decrease in diarrheal manifestations, as many long-term studies of adult and pediatric patients predating the use of these markers have documented this shift in clinical presentation. Of note, since the advent of sensitive and specific serologic assays over the past 2 decades, the gap between initial presentation of symptoms and diagnosis in symptomatic children has been gradually reduced. This reduction in duration of symptoms has also been documented in adults.


Breastfeeding practices appear to influence the mode of presentation in children, because children exclusively breastfed seem to less likely present with failure to thrive and short stature. Breast feeding also contributes to delaying the age of presentation of the disease and possibly preventing the disease. In addition, there is an association between cesarean delivery and development of celiac disease.




Adults


The major mode of presentation of celiac disease in adults is diarrhea, although this presentation occurs in fewer than 50% of patients. Other presentations include anemia, mainly caused by iron deficiency, though anemia due to nutritional factors and chronic disease may also be present at diagnosis of celiac disease. Anemia is more frequently seen at presentation in adults than in children.


Osteoporosis is another presentation of celiac disease in adults. Reduced bone density is common in patients with celiac disease, and there is increased risk of fracture. Research from Argentina demonstrated a high prevalence of bone fractures in the peripheral skeleton, mostly occurring before diagnosis or in noncompliant patients. Of interest, a population-based study from Sweden showed both adults and children with celiac disease were at increased risk of fracture. A study from the United States demonstrated an increased prevalence of celiac disease among osteoporotic patients. However, this finding was not confirmed by other studies from France and among postmenopausal women in Turkey.


Another mode of presentation is the incidental recognition of signs of villous atrophy caused by celiac disease during endoscopy performed for other indications. Most upper endoscopy procedures in adults are performed for gastroesophageal reflux disease (GERD). When celiac disease is recognized and treated in patients with GERD, improvement in the reflux is frequently noted. There is a reasonable argument for routine duodenal biopsies during endoscopy for adults, as is the usual practice for pediatric gastroenterologists.


Other presentations in adults include dermatitis herpetiformis, IBS, bloating, and chronic fatigue, as well as a variety of neurologic presentations. Many of the symptoms of celiac disease are common, frequently seen among patients attending primary care physicians. In the authors’ multicenter North American primary care screening study involving patients with a variety of symptoms including bloating, fatigue, recurrent abdominal pain, and IBS, screening for celiac disease resulted in a 40-fold increase in the rate of diagnosis of celiac disease.




Adults


The major mode of presentation of celiac disease in adults is diarrhea, although this presentation occurs in fewer than 50% of patients. Other presentations include anemia, mainly caused by iron deficiency, though anemia due to nutritional factors and chronic disease may also be present at diagnosis of celiac disease. Anemia is more frequently seen at presentation in adults than in children.


Osteoporosis is another presentation of celiac disease in adults. Reduced bone density is common in patients with celiac disease, and there is increased risk of fracture. Research from Argentina demonstrated a high prevalence of bone fractures in the peripheral skeleton, mostly occurring before diagnosis or in noncompliant patients. Of interest, a population-based study from Sweden showed both adults and children with celiac disease were at increased risk of fracture. A study from the United States demonstrated an increased prevalence of celiac disease among osteoporotic patients. However, this finding was not confirmed by other studies from France and among postmenopausal women in Turkey.


Another mode of presentation is the incidental recognition of signs of villous atrophy caused by celiac disease during endoscopy performed for other indications. Most upper endoscopy procedures in adults are performed for gastroesophageal reflux disease (GERD). When celiac disease is recognized and treated in patients with GERD, improvement in the reflux is frequently noted. There is a reasonable argument for routine duodenal biopsies during endoscopy for adults, as is the usual practice for pediatric gastroenterologists.


Other presentations in adults include dermatitis herpetiformis, IBS, bloating, and chronic fatigue, as well as a variety of neurologic presentations. Many of the symptoms of celiac disease are common, frequently seen among patients attending primary care physicians. In the authors’ multicenter North American primary care screening study involving patients with a variety of symptoms including bloating, fatigue, recurrent abdominal pain, and IBS, screening for celiac disease resulted in a 40-fold increase in the rate of diagnosis of celiac disease.




Asymptomatic presentations


Serologic screening of groups at risk is undoubtedly responsible for the increased detection of celiac disease in children, some of whom are asymptomatic. Screening was the mode of diagnosis of about 25% of children seen in the authors’ center ; this includes those identified as a result of serologic screening of family members and those with associated autoimmune conditions. Similarly, for adults there has been an increased number of diagnoses attributable to screening of at-risk groups. At present, about 10% of those adults diagnosed with celiac disease seen in the Celiac Disease Center at Columbia University in New York presented through screening of at-risk groups. Not all of those individuals detected by screening are truly asymptomatic.


Several high-risk groups are commonly screened. The most frequently at-risk group screened is the group of family members of individuals with celiac disease. Several studies have shown that about 4% to 10% of first-degree relatives have the disease. The greatest risk is among siblings of affected individuals, but the risk extends to second-degree relatives as well. Other frequently screened groups include those with type 1 diabetes (3%–7%) and autoimmune liver disease.


The reason why some patients present with diarrhea whereas others are asymptomatic is not clear, for there is no correlation of a diarrheal presentation with severity of villous atrophy, nor length of bowel involved as assessed by video capsule endoscopy. Neurohumoral mechanisms may be important in determining the presence of symptoms, as patients with celiac disease had increased mucosal 5-hydroxytryptamine content and enhanced release from the upper small bowel, which correlated with postprandial dyspepsia.




Associated conditions


Although the list of conditions associated with celiac disease is extensive, several groups are more frequently targeted for celiac disease screening because of their strong association. The association between celiac disease and type 1 diabetes in children is well described. The coexistence of both diseases also occurs in adults. The onset of diabetes generally precedes that of celiac disease. An increased prevalence of celiac disease has also been described in adults and children with autoimmune thyroid disease.


Children and adolescents with autoimmune liver disease, including biliary disease, have a high prevalence of celiac disease. An increased prevalence of celiac disease has additionally been identified in children with Down syndrome (7%), Turner syndrome (6.4%), and Williams syndrome (9.5%).


Several other conditions have been associated with celiac disease, including: autoimmune myocarditis; idiopathic dilated cardiomyopathy; Sjögren syndrome; immunoglobulin A (IgA) deficiency; Addison disease; IgA nephropathy; sarcoidosis; primary hyperparathyroidism; alopecia areata; vitiligo; neurologic abnormalities including epilepsy, ataxia, and neuropathy; atopy; inflammatory bowel disease; psoriasis; and chronic urticaria.


The association with celiac disease and autoimmune disorders is strong. About 30% of adult patients with celiac disease have one or more autoimmune disorder, compared with about 3% in the general population. The mechanism of these comorbidities is unclear. It has been suggested that the increase is associated with the duration of exposure to gluten, although this hypothesis has not been corroborated by other studies. In a study from France, however, after the diagnosis of celiac disease those who were strictly adherent to the gluten-free diet acquired fewer autoimmune disorders than those who were not compliant with the diet. This finding indicates that the diet may be protective against the development of autoimmune diseases. However, the institution of a gluten-free diet did not prevent progression of established autoimmune thyroid disease after the diagnosis of celiac disease.


Celiac disease is also associated with infertility in both women and men. Screening of infertile women detects undiagnosed celiac disease. Fertility improves after diagnosis of celiac disease.




Terminology and definitions


There have been several terms used to classify the presentations of celiac disease in both childhood and adulthood. Such terms as typical, atypical, classic, nonclassic, silent, asymptomatic, latent, and potential celiac disease have added confusion to the topic. Two extensive reviews have been published recently in an attempt to bring clarity and agreement to the field.



References



  1. 1. Andersen D.H.: Celiac syndrome. J Pediatr 1947; 30: pp. 564-582

  2. 2. Dickie W.K.: Coeliac disease. Investigation of the harmful effects of certain types of cereal on patients with coeliac disease. Utrecht (The Netherlands): Thesis, University of Utrecht, 1950.

  3. 3. Wilson R.: The coeliac syndrome with adolescent rickets. Ir J Med Sci 1951; 6: pp. 39-42

  4. 4. Sleisenger M.H., Rynbergen H.J., Pert J.H., et al: Treatment of non-tropical sprue: a wheat-, rye-, and oat-free diet. J Am Diet Assoc 1957; 33: pp. 1137-1140

  5. 5. Benson G.D., Kowlessar O.D., and Sleisenger M.H.: Adult celiac disease with emphasis upon response to the gluten-free diet. Medicine (Baltimore) 1964; 43: pp. 1-40

  6. 6. Mortimer P.E., Stewart J.S., Norman A.P., et al: Follow-up study of coeliac disease. Br Med J 1968; 3: pp. 7-9

  7. 7. Rampertab S.D., Pooran N., Brar P., et al: Trends in the presentation of celiac disease. Am J Med 2006; 119: pp. 355.e9-355.e14

  8. 8. Vivas S., Ruiz de Morales J.M., Fernandez M., et al: Age-related clinical, serological, and histopathological features of celiac disease. Am J Gastroenterol 2008; 103: pp. 2360-2365

  9. 9. Telega G., Bennet T.R., and Werlin S.: Emerging new clinical patterns in the presentation of celiac disease. Arch Pediatr Adolesc Med 2008; 162: pp. 164-168

  10. 10. Llorente-Alonso M., Fernandez-Acenero M.J., and Sebastian M.: Gluten intolerance: gender and age-related features. Can J Gastroenterol 2006; 20: pp. 719-722

  11. 11. Branski D., and Troncone R.: Celiac disease: a reappraisal. J Pediatr 1998; 133: pp. 181-187

  12. 12. Ludvigsson J.F., Ansved P., Falth-Magnusson K., et al: Symptoms and signs have changed in Swedish children with coeliac disease. J Pediatr Gastroenterol Nutr 2004; 38: pp. 181-186

  13. 13. Reilly N.R., Aguilar K., Hassid B.G., et al: Celiac disease in normal-weight and overweight children: clinical features and growth outcomes following a gluten-free diet. J Pediatr Gastroenterol Nutr 2011; 53: pp. 528-531

  14. 14. Dehghani S.M., and Asadi-Pooya A.A.: Celiac disease in children with short stature. Indian J Pediatr 2008; 75: pp. 131-133

  15. 15. Sidhu S.K., Koulaouzidis A., and Tan C.W.: Coeliac disease inducing mesenteric lymphadenopathy and intussusception. Intern Med J 2011; 41: pp. 434

  16. 16. Scholz D., Alzen G., and Zimmer K.P.: Re: small bowel intussusception in celiac disease: revisiting a classic association. J Pediatr Gastroenterol Nutr 2011; 52: pp. 117-118

  17. 17. Mirk P., Foschi R., Minordi L.M., et al: Sonography of the small bowel after oral administration of fluid: an assessment of the diagnostic value of the technique. Radiol Med 2012; 117: pp. 558-574

  18. 18. Fishman D.S., Chumpitazi B.P., Ngo P.D., et al: Small bowel intussusception in celiac disease: revisiting a classic association. J Pediatr Gastroenterol Nutr 2010; 50: pp. 237

  19. 19. Altaf M.A., and Grunow J.E.: Atypical presentations of celiac disease: recurrent intussusception and pneumatosis intestinalis. Clin Pediatr (Phila) 2008; 47: pp. 289-292

  20. 20. Gonda T.A., Khan S.U., Cheng J., et al: Association of intussusception and celiac disease in adults. Dig Dis Sci 2010; 55: pp. 2899-2903

  21. 21. Sanders D.S., Azmy I.A., Kong S.C., et al: Symptomatic small bowel intussusception: a surgical opportunity to diagnose adult celiac disease? Gastrointest Endosc 2004; 59: pp. 161-162

  22. 22. Pueschel S.M., Romano C., Failla P., et al: A prevalence study of celiac disease in persons with Down syndrome residing in the United States of America. Acta Paediatr 1999; 88: pp. 953-956

  23. 23. Rizkalla Reilly N., Dixit R., Simpson S., et al: Celiac disease in children: an old disease with new features. Minerva Pediatr 2012; 64: pp. 71-81

  24. 24. McGowan K.E., Castiglione D.A., and Butzner J.D.: The changing face of childhood celiac disease in north america: impact of serological testing. Pediatrics 2009; 124: pp. 1572-1578

  25. 25. Lo W., Sano K., Lebwohl B., et al: Changing presentation of adult celiac disease. Dig Dis Sci 2003; 48: pp. 395-398

  26. 26. Pelleboer R.A., Janssen R.L., Deckers-Kocken J.M., et al: Celiac disease is overrepresented in patients with constipation. J Pediatr (Rio J) 2012; 88: pp. 173-176

  27. 27. Venkatasubramani N., Telega G., and Werlin S.L.: Obesity in pediatric celiac disease. J Pediatr Gastroenterol Nutr 2010; 51: pp. 295-297

  28. 28. Arslan N., Esen I., Demircioglu F., et al: The changing face of celiac disease: a girl with obesity and celiac disease. J Paediatr Child Health 2009; 45: pp. 317-318

  29. 29. Kabbani T.A., Goldberg A., Kelly C.P., et al: Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther 2012; 35: pp. 723-729

  30. 30. Cheng J., Brar P.S., Lee A.R., et al: Body mass index in celiac disease: beneficial effect of a gluten-free diet. J Clin Gastroenterol 2010; 44: pp. 267-271

  31. 31. Garampazzi A., Rapa A., Mura S., et al: Clinical pattern of celiac disease is still changing. J Pediatr Gastroenterol Nutr 2007; 45: pp. 611-614

  32. 32. Sun S., Puttha R., Ghezaiel S., et al: The effect of biopsy-positive silent coeliac disease and treatment with a gluten-free diet on growth and glycaemic control in children with type 1 diabetes. Diabet Med 2009; 26: pp. 1250-1254

  33. 33. Savilahti E., Pelkonen P., and Visakorpi J.K.: IgA deficiency in children. A clinical study with special reference to intestinal findings. Arch Dis Child 1971; 46: pp. 665-670

  34. 34. D’Amico M.A., Holmes J., Stavropoulos S.N., et al: Presentation of pediatric celiac disease in the united states: prominent effect of breastfeeding. Clin Pediatr (Phila) 2005; 44: pp. 249-258

  35. 35. Vella C., and Grech V.: Increasing age at diagnosis of celiac disease in Malta. Indian J Pediatr 2004; 71: pp. 581-582

  36. 36. Ivarsson A., Hernell O., Stenlund H., et al: Breast-feeding protects against celiac disease. Am J Clin Nutr 2002; 75: pp. 914-921

  37. 37. Peters U., Schneeweiss S., Trautwein E.A., et al: A case-control study of the effect of infant feeding on celiac disease. Ann Nutr Metab 2001; 45: pp. 135-142

  38. 38. Marild K., Stephansson O., Montgomery S., et al: Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. Gastroenterology 2012; 142: pp. 39-45.e3

  39. 39. Decker E., Hornef M., and Stockinger S.: Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Gut Microbes 2011; 2: pp. 91-98

  40. 40. Harper J.W., Holleran S.F., Ramakrishnan R., et al: Anemia in celiac disease is multifactorial in etiology. Am J Hematol 2007; 82: pp. 996-1000

  41. 41. Bergamaschi G., Markopoulos K., Albertini R., et al: Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica 2008; 93: pp. 1785-1791

  42. 42. Rodrigo-Saez L., Fuentes-Alvarez D., Perez-Martinez I., et al: Differences between pediatric and adult celiac disease. Rev Esp Enferm Dig 2011; 103: pp. 238-244

  43. 43. Valdimarsson T., Toss G., Ross I., et al: Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: pp. 457-461

  44. 44. Meyer D., Stavropolous S., Diamond B., et al: Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol 2001; 96: pp. 112-119

  45. 45. Vasquez H., Mazure R., Gonzalez D., et al: Risk of fractures in celiac disease patients: a cross-sectional, case- control study. Am J Gastroenterol 2000; 95: pp. 183-189

  46. 46. West J., Logan R.F., Card T.R., et al: Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 2003; 125: pp. 429-436

  47. 47. Ludvigsson J.F., Michaelsson K., Ekbom A., et al: Coeliac disease and the risk of fractures—a general population-based cohort study. Aliment Pharmacol Ther 2007; 25: pp. 273-285

  48. 48. Stenson W.F., Newberry R., Lorenz R., et al: Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 2005; 165: pp. 393-399

  49. 49. Legroux-Gerot I., Leloire O., Blanckaert F., et al: Screening for celiac disease in patients with osteoporosis. Joint Bone Spine 2009; 76: pp. 162-165

  50. 50. Kavuncu V., Dundar U., Ciftci I.H., et al: Is there any requirement for celiac disease screening routinely in postmenapausal women with osteoporosis? Rheumatol Int 2009; 29: pp. 841-845

  51. 51. Green P.H., Shane E., Rotterdam H., et al: Significance of unsuspected celiac disease detected at endoscopy. Gastrointest Endosc 2000; 51: pp. 60-65

  52. 52. Nachman F., Vazquez H., Gonzalez A., et al: Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet. Clin Gastroenterol Hepatol 2011; 9: pp. 214-219

  53. 53. Green P.H., and Murray J.A.: Routine duodenal biopsies to exclude celiac disease? Gastrointest Endosc 2003; 58: pp. 92-95

  54. 54. Chin R.L., Latov N., Green P.H., et al: Neurologic complications of celiac disease. J Clin Neuromuscul Dis 2004; 5: pp. 129-137

  55. 55. Hin H., Bird G., Fisher P., et al: Coeliac disease in primary care: case finding study. BMJ 1999; 318: pp. 164-167

  56. 56. Catassi C., Kryszak D., Louis-Jacques O., et al: Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol 2007; 102: pp. 1454-1460

  57. 57. Fasano A., Berti I., Gerarduzzi T., et al: Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: pp. 286-292

  58. 58. Aggarwal S., Lebwohl B., and Green P.H.: Screening for celiac disease in average-risk and high-risk populations. Therap Adv Gastroenterol 2012; 5: pp. 37-47

  59. 59. Murray J.A.: Celiac disease in patients with an affected member, type 1 diabetes, iron-deficiency, or osteoporosis? Gastroenterology 2005; 128: pp. S52-S56

  60. 60. Book L., Zone J.J., and Neuhausen S.L.: Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol 2003; 98: pp. 377-381

  61. 61. Dickey W., and McMillan S.A.: Co-screening for primary biliary cirrhosis and coeliac disease. Association between primary biliary cirrhosis and coeliac disease. Gut 1998; 43: pp. 300

  62. 62. Volta U., Rodrigo L., Granito A., et al: Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 2002; 97: pp. 2609-2613

  63. 63. Brar P., Kwon G.Y., Egbuna I., et al: Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis 2007; 39: pp. 26-29

  64. 64. Murray J.A., Rubio-Tapia A., Van Dyke C.T., et al: Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol 2008; 6: pp. 186-193

  65. 65. Coleman N.S., Foley S., Dunlop S.P., et al: Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol 2006; 4: pp. 874-881

  66. 66. Carlsson A.K., Axelsson I.E., Borulf S.K., et al: Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics 1999; 103: pp. 1248-1252

  67. 67. Walsh C.H., Cooper B.T., Wright A.D., et al: Diabetes mellitus and coeliac disease: a clinical study. Q J Med 1978; 47: pp. 89-100

  68. 68. Bouguerra R., Ben Salem L., Chaabouni H., et al: Celiac disease in adult patients with type 1 diabetes mellitus in Tunisia. Diabetes Metab 2005; 31: pp. 83-86

  69. 69. Sategna-Guidetti C., Volta U., Ciacci C., et al: Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol 2001; 96: pp. 751-757

  70. 70. Sategna-Guidetti C., Bruno M., Mazza E., et al: Autoimmune thyroid diseases and coeliac disease. Eur J Gastroenterol Hepatol 1998; 10: pp. 927-931

  71. 71. Sattar N., Lazare F., Kacer M., et al: Celiac disease in children, adolescents, and young adults with autoimmune thyroid disease. J Pediatr 2011; 158: pp. 272-275.e1

  72. 72. Caprai S., Vajro P., Ventura A., et al: Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin Gastroenterol Hepatol 2008; 6: pp. 803-806

  73. 73. Diamanti A., Basso M.S., Pietrobattista A., et al: Prevalence of celiac disease in children with autoimmune hepatitis. Dig Liver Dis 2008; 40: pp. 965

  74. 74. George E.K., Hertzberger-ten Cate R., van Suijlekom-Smit L.W., et al: Juvenile chronic arthritis and coeliac disease in The Netherlands. Clin Exp Rheumatol 1996; 14: pp. 571-575

  75. 75. Bonamico M., Pasquino A.M., Mariani P., et al: Prevalence and clinical picture of celiac disease in turner syndrome. J Clin Endocrinol Metab 2002; 87: pp. 5495-5498

  76. 76. Bonamico M., Mariani P., Danesi H.M., et al: Prevalence and clinical picture of celiac disease in Italian Down syndrome patients: a multicenter study. J Pediatr Gastroenterol Nutr 2001; 33: pp. 139-143

  77. 77. Bai D., Brar P., Holleran S., et al: Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men. Scand J Gastroenterol 2005; 40: pp. 183-187

  78. 78. Ventura A., Magazzu G., and Greco L.: Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999; 117: pp. 297-303

  79. 79. Jacobson D.L., Gange S.J., Rose N.R., et al: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: pp. 223-243

  80. 80. Sategna-Guidetti C., Solerio E., Scaglione N., et al: Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 2001; 49: pp. 502-505

  81. 81. Viljamaa M., Kaukinen K., Huhtala H., et al: Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol 2005; 40: pp. 437-443

  82. 82. Cosnes J., Cellier C., Viola S., et al: Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 2008; 6: pp. 753-758

  83. 83. Metso S., Hyytia-Ilmonen H., Kaukinen K., et al: Gluten-free diet and autoimmune thyroiditis in patients with celiac disease. A prospective controlled study. Scand J Gastroenterol 2012; 47: pp. 43-48

  84. 84. Molteni N., Bardella M.T., and Bianchi P.A.: Obstetric and gynecological problems in women with untreated celiac sprue. J Clin Gastroenterol 1990; 12: pp. 37-39

  85. 85. Sher K.S., and Mayberry J.F.: Female fertility, obstetric and gynaecological history in coeliac disease. A case control study. Digestion 1994; 55: pp. 243-246

  86. 86. Stazi A.V., and Mantovani A.: A risk factor for female fertility and pregnancy: celiac disease. Gynecol Endocrinol 2000; 14: pp. 454-463

  87. 87. Baker P.G., and Read A.E.: Reversible infertility in male coeliac patients. Br Med J 1975; 02: pp. 316-317

  88. 88. Choi J.M., Lebwohl B., Wang J., et al: Increased prevalence of celiac disease in patients with unexplained infertility in the United States. J Reprod Med 2011; 56: pp. 199-203

  89. 89. Zugna D., Richiardi L., Akre O., et al: A nationwide population-based study to determine whether coeliac disease is associated with infertility. Gut 2010; 59: pp. 1471-1475

  90. 90. Ludvigsson J.F., Leffler D.A., Bai J.C., et al: The Oslo definitions for coeliac disease and related terms. Gut 2012; undefined:

  91. 91. Sapone A., Bai J.C., Ciacci C., et al: Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 2012; 10: pp. 13

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 12, 2017 | Posted by in GASTOINESTINAL SURGERY | Comments Off on Presentation of Celiac Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access